Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
Is exercise during chemotherapy helpful in protecting heart function?
Trialing prescription drugs to activate brown adipose tissue as a possible treatment for obesity
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
Specialists are warning against apathy toward CVD research in light of an apparent ‘disease fatigue’ that has robbed the sector of funding momentum. Find out more
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more